RU2592674C2 - Аллергены, полученные рекомбинантными способами - Google Patents
Аллергены, полученные рекомбинантными способами Download PDFInfo
- Publication number
- RU2592674C2 RU2592674C2 RU2011153388/10A RU2011153388A RU2592674C2 RU 2592674 C2 RU2592674 C2 RU 2592674C2 RU 2011153388/10 A RU2011153388/10 A RU 2011153388/10A RU 2011153388 A RU2011153388 A RU 2011153388A RU 2592674 C2 RU2592674 C2 RU 2592674C2
- Authority
- RU
- Russia
- Prior art keywords
- allergen
- protein
- dog
- ige
- sequence
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 145
- 238000010188 recombinant method Methods 0.000 title claims abstract description 42
- 241000282472 Canis lupus familiaris Species 0.000 claims abstract description 99
- 208000001840 Dandruff Diseases 0.000 claims abstract description 58
- 206010020751 Hypersensitivity Diseases 0.000 claims abstract description 45
- 230000007815 allergy Effects 0.000 claims abstract description 45
- 208000026935 allergic disease Diseases 0.000 claims abstract description 33
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 25
- 238000000338 in vitro Methods 0.000 claims abstract description 9
- 239000012634 fragment Substances 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 10
- 150000007523 nucleic acids Chemical class 0.000 claims description 10
- 238000003745 diagnosis Methods 0.000 claims description 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 7
- 230000000890 antigenic effect Effects 0.000 claims description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 6
- 102000039446 nucleic acids Human genes 0.000 claims description 6
- 239000013598 vector Substances 0.000 claims description 4
- 238000009007 Diagnostic Kit Methods 0.000 claims description 3
- 239000013060 biological fluid Substances 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000002268 wool Anatomy 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 117
- 102000004169 proteins and genes Human genes 0.000 description 113
- 235000018102 proteins Nutrition 0.000 description 106
- 241000283725 Bos Species 0.000 description 58
- 230000027455 binding Effects 0.000 description 46
- 241000283690 Bos taurus Species 0.000 description 36
- 239000000284 extract Substances 0.000 description 34
- 229960004784 allergens Drugs 0.000 description 27
- 238000004458 analytical method Methods 0.000 description 26
- 230000002009 allergenic effect Effects 0.000 description 21
- 210000002966 serum Anatomy 0.000 description 21
- 239000002299 complementary DNA Substances 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 238000000746 purification Methods 0.000 description 20
- 208000010668 atopic eczema Diseases 0.000 description 18
- 230000000172 allergic effect Effects 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 230000000875 corresponding effect Effects 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 238000003119 immunoblot Methods 0.000 description 15
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 230000009260 cross reactivity Effects 0.000 description 14
- 230000001900 immune effect Effects 0.000 description 13
- 230000004044 response Effects 0.000 description 12
- 108050006654 Lipocalin Proteins 0.000 description 11
- 102000019298 Lipocalin Human genes 0.000 description 11
- 101150073669 NCAN gene Proteins 0.000 description 11
- 125000000539 amino acid group Chemical group 0.000 description 11
- 238000001542 size-exclusion chromatography Methods 0.000 description 11
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 10
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 10
- 206010070834 Sensitisation Diseases 0.000 description 10
- 238000005571 anion exchange chromatography Methods 0.000 description 10
- 230000008313 sensitization Effects 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 241000124008 Mammalia Species 0.000 description 7
- 108010076504 Protein Sorting Signals Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 239000011780 sodium chloride Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 6
- 229940074608 allergen extract Drugs 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 238000002405 diagnostic procedure Methods 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 102000052563 odorant-binding protein Human genes 0.000 description 6
- 108010000645 odorant-binding protein Proteins 0.000 description 6
- 238000013519 translation Methods 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 101150033839 4 gene Proteins 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 108700024394 Exon Proteins 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 238000005277 cation exchange chromatography Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 206010001742 Allergy to animal Diseases 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 102000001708 Protein Isoforms Human genes 0.000 description 3
- 108010029485 Protein Isoforms Proteins 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 230000008033 biological extinction Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004899 c-terminal region Anatomy 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 2
- 101710154545 16 kDa protein Proteins 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 235000004266 Cynoglossum officinale Nutrition 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000004988 N-glycosylation Effects 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 101710176384 Peptide 1 Proteins 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- 239000012505 Superdex™ Substances 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005206 flow analysis Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007030 peptide scission Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229940043131 pyroglutamate Drugs 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 101710150034 Allergen Bos d 2 Proteins 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 239000007989 BIS-Tris Propane buffer Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 240000004487 Cynoglossum officinale Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 241001521135 Fringilla coelebs Species 0.000 description 1
- 108010001517 Galectin 3 Proteins 0.000 description 1
- 102100039558 Galectin-3 Human genes 0.000 description 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
- 102000028554 IgE binding proteins Human genes 0.000 description 1
- 108091009324 IgE binding proteins Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 241000080590 Niso Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001465379 Parietaria judaica Species 0.000 description 1
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 1
- 208000008425 Protein deficiency Diseases 0.000 description 1
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000012435 analytical chromatography Methods 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- HHKZCCWKTZRCCL-UHFFFAOYSA-N bis-tris propane Chemical compound OCC(CO)(CO)NCCCNC(CO)(CO)CO HHKZCCWKTZRCCL-UHFFFAOYSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 102000007579 human kallikrein-related peptidase 3 Human genes 0.000 description 1
- 108010071652 human kallikrein-related peptidase 3 Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 230000001024 immunotherapeutic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000010807 negative regulation of binding Effects 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000013573 pollen allergen Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000013615 primer Substances 0.000 description 1
- 230000009145 protein modification Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 125000002987 valine group Chemical group [H]N([H])C([H])(C(*)=O)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0950416-8 | 2009-06-05 | ||
| SE0950416 | 2009-06-05 | ||
| PCT/SE2010/050623 WO2010140973A1 (en) | 2009-06-05 | 2010-06-04 | Recombinantly produced allergens |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2011153388A RU2011153388A (ru) | 2013-07-20 |
| RU2592674C2 true RU2592674C2 (ru) | 2016-07-27 |
Family
ID=43297952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2011153388/10A RU2592674C2 (ru) | 2009-06-05 | 2010-06-04 | Аллергены, полученные рекомбинантными способами |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9243045B2 (enExample) |
| EP (1) | EP2438082B1 (enExample) |
| JP (1) | JP5793138B2 (enExample) |
| CN (1) | CN102459323B (enExample) |
| AU (1) | AU2010254626B2 (enExample) |
| CA (1) | CA2763075C (enExample) |
| DK (1) | DK2438082T3 (enExample) |
| ES (1) | ES2505245T3 (enExample) |
| PL (1) | PL2438082T3 (enExample) |
| RU (1) | RU2592674C2 (enExample) |
| SI (1) | SI2438082T1 (enExample) |
| WO (1) | WO2010140973A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2845385C1 (ru) * | 2024-05-20 | 2025-08-18 | Федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И. М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) | Рекомбинантный аллерген Can f 5, полученный в клетках E.coli |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105353134A (zh) * | 2015-11-17 | 2016-02-24 | 苏州浩欧博生物医药有限公司 | 检测狗毛过敏原特异性IgE抗体的试剂盒及方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2285042C2 (ru) * | 2000-11-16 | 2006-10-10 | Альк-Абелло А/С | Новые мутантные аллергены |
| EP2000531A1 (en) * | 2007-06-06 | 2008-12-10 | Biomay AG | Antigen presenting cells |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4459360A (en) * | 1981-10-05 | 1984-07-10 | Mast Medical Industries, Ltd. | Multiple-component binding assay system and method of making and using it |
-
2010
- 2010-06-04 CA CA2763075A patent/CA2763075C/en active Active
- 2010-06-04 RU RU2011153388/10A patent/RU2592674C2/ru active
- 2010-06-04 SI SI201030735T patent/SI2438082T1/sl unknown
- 2010-06-04 ES ES10783670.2T patent/ES2505245T3/es active Active
- 2010-06-04 AU AU2010254626A patent/AU2010254626B2/en active Active
- 2010-06-04 EP EP10783670.2A patent/EP2438082B1/en active Active
- 2010-06-04 PL PL10783670T patent/PL2438082T3/pl unknown
- 2010-06-04 WO PCT/SE2010/050623 patent/WO2010140973A1/en not_active Ceased
- 2010-06-04 DK DK10783670.2T patent/DK2438082T3/da active
- 2010-06-04 US US13/375,836 patent/US9243045B2/en active Active
- 2010-06-04 CN CN201080025013.4A patent/CN102459323B/zh active Active
- 2010-06-04 JP JP2012513906A patent/JP5793138B2/ja active Active
-
2015
- 2015-12-30 US US14/984,482 patent/US9757447B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2285042C2 (ru) * | 2000-11-16 | 2006-10-10 | Альк-Абелло А/С | Новые мутантные аллергены |
| EP2000531A1 (en) * | 2007-06-06 | 2008-12-10 | Biomay AG | Antigen presenting cells |
Non-Patent Citations (2)
| Title |
|---|
| LUNDGREN T. et al., Cloning and characterization of dog allergen Can f 4, 28th Congress of the European Academy of Allergy and Clinical Immunology, Poland, Warzawa, 2009, p. 179-538, найдено в Интернет [17.02.2014] по адресу: http://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2009.02076.x/pdf. * |
| SAARLAINEN S. et al., Assessment of recombinant dog allergens Can f1 and Can f 2 for the diagnosis of dog allergy, Clin. Exp. Allergy, 2004, v. 34, p. 1576-1582;. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2845385C1 (ru) * | 2024-05-20 | 2025-08-18 | Федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И. М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет) | Рекомбинантный аллерген Can f 5, полученный в клетках E.coli |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010254626A1 (en) | 2011-12-22 |
| ES2505245T3 (es) | 2014-10-09 |
| AU2010254626B2 (en) | 2014-08-07 |
| US20160114031A1 (en) | 2016-04-28 |
| US9757447B2 (en) | 2017-09-12 |
| JP2012528591A (ja) | 2012-11-15 |
| CN102459323B (zh) | 2015-08-05 |
| EP2438082A4 (en) | 2012-10-10 |
| PL2438082T3 (pl) | 2014-11-28 |
| CN102459323A (zh) | 2012-05-16 |
| EP2438082B1 (en) | 2014-08-06 |
| US20120076826A1 (en) | 2012-03-29 |
| JP5793138B2 (ja) | 2015-10-14 |
| RU2011153388A (ru) | 2013-07-20 |
| CA2763075C (en) | 2019-11-26 |
| SI2438082T1 (sl) | 2014-11-28 |
| WO2010140973A1 (en) | 2010-12-09 |
| DK2438082T3 (da) | 2014-09-22 |
| EP2438082A1 (en) | 2012-04-11 |
| CA2763075A1 (en) | 2010-12-09 |
| US9243045B2 (en) | 2016-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mattsson et al. | Molecular and immunological characterization of Can f 4: a dog dander allergen cross‐reactive with a 23 kDa odorant‐binding protein in cow dander | |
| US9518987B2 (en) | Prostate kallikrein allergen | |
| US9757447B2 (en) | Recombinantly produced allergens | |
| JP6280578B2 (ja) | 新規のアレルゲン | |
| JP6785216B2 (ja) | 新規アレルゲン | |
| HK1161913B (en) | Method for identifying allergenic proteins and peptides |